Curtis Granderson dealing with hamstring tendinitis, could play Sunday

20 Comments

UPDATE: Good news for the Bombers. According to Erik Boland of New York Newsday, Yankees manager Joe Girardi said the MRI didn’t show anything serious. He’s dealing with some “mild tendinitis” and could play as soon as tomorrow.

2:27 PM: Things just aren’t going the Yankees’ way right now.

Curtis Granderson was forced to leave this afternoon’s game against the Orioles after just two innings due to tightness in his right hamstring. More should be known on his status after he undergoes a precautionary MRI.

Ichiro Suzuki moved over to center field after Granderson exited and should get most of the playing time there for now. Alex Rodriguez began a minor league rehab assignment last night and is likely just a couple of days away from returning from the disabled list, but this Yankees’ lineup isn’t nearly as scary with Granderson and Mark Teixeira both sidelined.

Report: Phillies moving in on a deal with Tommy Hunter

Victor Decolongon/Getty Images
Leave a comment

Update (8:40 PM ET): Joel Sherman of the New York Post reports that Hunter’s contract with the Phillies is for two years.

*

There’s been a bit of confusion at the Winter Meetings. First, ESPN’s Buster Olney reported that the Phillies were close to signing free agent reliever Addison Reed. That report was then disputed by Jon Heyman of FanRag Sports. Matt Gelb of the Philadelphia Inquirer then reported that not only do the Phillies not have a deal with Reed, they’re actually moving in on a deal with free agent pitcher Tommy Hunter. Ken Rosenthal of The Athletic backed up Gelb’s report, as did Todd Zolecki of MLB.com.

Hunter, 31, spent the past season with the Rays, posting a 2.61 ERA with a 64/14 K/BB ratio across 58 2/3 innings. The right-hander, a veteran of 10 seasons in the majors, should be a good addition to the Phillies’ bullpen, which also recently added Pat Neshek. Neshek and Hunter will likely work the innings just ahead of closer Hector Neris.

As for Reed, well, who knows.